Durogesic

B. PATIENT INFORMATION LEAFLET

Leaflet accompanying the packaging: patient information

Durogesic, 12 µg/h, transdermal system, patch
Durogesic, 25 µg/h, transdermal system, patch
Durogesic, 50 µg/h, transdermal system, patch
Durogesic, 75 µg/h, transdermal system, patch
Durogesic, 100 µg/h, transdermal system, patch
fentanyl

Read the leaflet carefully before using the medicine, as it contains important information for the patient.

• Keep this leaflet, so you can read it again if you need to.
• If you have any doubts, consult your doctor, pharmacist, or nurse.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet

• 1. What is Durogesic and what is it used for
• 2. Important information before using Durogesic
• 3. How to use Durogesic
• 4. Possible side effects
• 5. How to store Durogesic
• 6. Contents of the packaging and other information

1. What is Durogesic and what is it used for

The name of this medicine is Durogesic.
Durogesic is indicated for the treatment of severe chronic pain:

• in adults who require continuous opioid treatment
• in children over 2 years of age who have already used opioid medications and require continuous opioid treatment.

Durogesic contains the active substance fentanyl, which is a strong pain reliever belonging to the opioid group.

2. Important information before using Durogesic

When not to use Durogesic

• if the patient is allergic to the active substance or any of the other ingredients of this medicine (listed in section 6),
• for short-term, acute, or post-operative pain,
• if the patient has severe respiratory depression (significant slowing and shallowing of breathing). Do not use this medicine if any of the above situations apply to the patient. In case of doubts, consult your doctor or pharmacist before using Durogesic.

Warnings and precautions

• Durogesic may cause life-threatening side effects in people who do not regularly use opioid medications.
• Durogesic is a medicine that can be life-threatening to children. This also applies to used patches. It should be considered that the appearance of the patch (used or not) may encourage a child to touch it, stick it to their body, put it in their mouth, etc., which can lead to death.
• This medicine should be stored in a safe and protected place, inaccessible to other people - more information on this can be found in section 5.

In case of accidental attachment of the Durogesic patch to another person's skin

Patches should only be applied to the skin of the person they were prescribed for. Several cases of accidental attachment of a patch to another person's skin have been reported during close physical contact or while sleeping in the same bed with the person using the patches. Accidental attachment of a patch to another person's skin (especially a child) can cause the medicine to be absorbed through the skin and lead to severe side effects, such as respiratory disorders with slow and shallow breathing, which can be life-threatening. If such a situation occurs, the patch should be removed immediately and a doctor consulted.

Special caution is required when using Durogesic

Consult your doctor or pharmacist before using this medicine if

any of the following situations apply- closer monitoring of the patient may be necessary, when:

• the patient has had lung disease or breathing difficulties,
• the patient has had heart, liver, kidney, or low blood pressure problems,
• the patient has had a brain tumor,
• the patient has had persistent headaches or head injuries,
• the patient is elderly - they may be more sensitive to the effects of this medicine,
• the patient has myasthenia gravis, a condition characterized by muscle weakness and fatigue.

If any of the above situations apply to the patient (or the patient is unsure), they should consult their doctor or pharmacist before using Durogesic.

During treatment with patches, inform your doctor if the patient experiences

breathing problems during sleep.Opioids, such as Durogesic, can cause breathing disorders during sleep, such as sleep apnea (pauses in breathing during sleep) and hypoxemia (low oxygen levels in the blood). Inform your doctor if the patient, their partner, or caregiver notices any of the following symptoms:

• pauses in breathing during sleep
• nighttime awakenings due to shortness of breath
• difficulty maintaining sleep
• excessive daytime sleepiness. The doctor may decide to change the dose of the medicine.

During treatment with patches, inform your doctor if the patient notices a change in

pain perception.If the patient feels that:

• the pain is no longer relieved after applying the patch
• the pain is worsening
• there is a change in the way the pain is perceived (e.g., the patient feels pain in a different part of the body)
• there is pain upon touch, which should not be present. Do not change the dose yourself. The doctor may decide to change the dose or treatment.

Side effects of Durogesic

• Durogesic may cause unnatural fatigue and slowed or shallow breathing. Although rare, these breathing disorders can be life-threatening or lead to death, especially in people who have not previously used opioid pain medications (such as Durogesic or morphine). If the patient, their partner, or caregiver notices that the person using the patches is excessively sleepy and has slow or shallow breathing, they should:
• remove the patch
• call a doctor or go to the nearest hospital immediately
• encourage the patient to move and talk as much as possible.
• If the patient develops a fever while using Durogesic, they should consult their doctor - an increase in body temperature can significantly increase the absorption of the medicine through the skin.
• Durogesic may cause constipation; consult your doctor or pharmacist on how to prevent or alleviate constipation. A full list of side effects can be found in section 4.

Durogesic, like other opioids, may affect the normal production of hormones in the body, such as cortisol, prolactin, or sex hormones, especially with long-term use. The consequences of these hormonal changes may include malaise (including nausea), loss of appetite, fatigue, weakness, dizziness, low blood pressure, infertility, or decreased sex drive. Additionally, women may experience changes in their menstrual cycle, and men may experience impotence or breast enlargement. If the patient notices any of these symptoms, they should consult their doctor.
Do not heat the patch application site with external heat sources, such as heated pads, electric blankets, hot water bottles, heated beds, heat lamps, or tanning beds. Do not sunbathe or use prolonged warming baths, saunas, or whirlpool baths. In these situations, there is a risk of increased release of the medicine from the patch.

Long-term use and tolerance

This medicine contains fentanyl, which is an opioid pain reliever. Repeated use of opioid pain relievers can lead to decreased effectiveness of the medicine (the patient becomes accustomed to it, known as tolerance). During treatment with Durogesic, the patient's sensitivity to pain may also increase. This phenomenon is known as hyperalgesia.
Increasing the patch dose may temporarily reduce the pain, but it can also be harmful. If the patient notices a decrease in the effectiveness of the medicine, they should consult their doctor. The doctor will decide whether it is better for the patient to increase the dose or gradually reduce the use of Durogesic.

Dependence and addictive use

Repeated use of Durogesic can also lead to dependence, abuse, and addictive use, which can result in life-threatening overdose. The risk of these side effects may increase with increasing dose and duration of use. Dependence or addictive use can cause the patient to feel a loss of control over the amount of medicine they use or how often they take it. The patient may feel the need to continue using the medicine, even if it no longer relieves their pain.
The risk of dependence or addictive use varies from person to person. The risk of dependence on Durogesic or its addictive use may be higher if:

• the patient or someone in their family has previously abused or been dependent on alcohol, prescription medications, or illegal substances (addiction);
• the patient smokes tobacco;
• the patient has previously experienced mood disorders (depression, anxiety disorders, or personality disorders) or has been treated by a psychiatrist for other mental health conditions.

If the patient experiences any of the following symptoms while using Durogesic, it may indicate dependence or addictive use.

• The patient needs to use the medicine for a longer period than prescribed by the doctor.
• The patient needs to use a higher dose than recommended.
• The patient uses the medicine for reasons other than those for which the doctor prescribed it, such as "to calm down" or "to fall asleep".
• The patient has repeatedly tried to stop or control the use of the medicine but has been unsuccessful.
• After stopping the use of the medicine, the patient feels unwell and experiences improvement in their condition when they start using the medicine again (withdrawal symptoms).

If the patient notices any of these symptoms, they should discuss the best treatment strategy with their doctor, including determining when it is appropriate to stop the treatment and how to safely end the treatment.

Withdrawal symptoms after stopping Durogesic

Do not stop using this medicine abruptly. Withdrawal symptoms may occur, such as anxiety, difficulty sleeping, irritability, restlessness, anxiety, rapid heartbeat (palpitations), increased blood pressure, nausea, vomiting, diarrhea, loss of appetite, tremors, chills, or sweating. If the patient wants to stop using this medicine, they should first consult their doctor. The doctor will inform them how to do it; usually, this is done by gradually reducing the dose, so that any unpleasant withdrawal symptoms are minimized. See also section 2 "Withdrawal symptoms after stopping Durogesic".

Durogesic and other medicines

Tell your doctor or pharmacist about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take. This includes all over-the-counter medicines and herbal remedies.
When buying other medicines at the pharmacy, tell the pharmacist that you are using Durogesic.
The attending doctor knows which medicines can be safely used with Durogesic. The patient will require close monitoring if they are using certain medicines listed below or if they stop using certain medicines listed below, as this may affect the required effectiveness of Durogesic.
In particular, tell your doctor or pharmacist if the patient is taking:

• Other opioid pain relievers (such as buprenorphine, nalbuphine, or pentazocine) and certain pain relievers used for neuropathic pain (gabapentin and pregabalin).
• Sleeping pills (such as temazepam, zaleplon, or zolpidem).
• Sedatives (such as alprazolam, clonazepam, diazepam, hydroxyzine, or lorazepam) and antipsychotic medicines (such as aripiprazole, haloperidol, olanzapine, risperidone, or phenothiazines).
• Muscle relaxants (such as cyclobenzaprine or diazepam).
• Certain antidepressants called SSRIs or SNRIs (such as citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, or venlafaxine) - see below.
• Certain antidepressants or medicines used to treat Parkinson's disease called MAOIs (such as isocarboxazid, phenelzine, selegiline, or tranylcypromine). Do not use Durogesic for 14 days after stopping these medicines - see below.
• Certain antihistamines, especially those that cause drowsiness (such as chlorpheniramine, clemastine, cyproheptadine, diphenhydramine, or hydroxyzine).
• Certain antibiotics (such as erythromycin or clarithromycin).
• Antifungal medicines (such as itraconazole, ketoconazole, fluconazole, or voriconazole).
• Medicines used to treat HIV infection (such as ritonavir).
• Anti-arrhythmic medicines (such as amiodarone, diltiazem, or verapamil).
• Anti-tuberculosis medicines (such as rifampicin).
• Certain anti-epileptic medicines (such as carbamazepine, phenobarbital, or phenytoin).
• Certain medicines used to treat nausea and motion sickness (such as phenothiazines).
• Certain medicines used to treat heartburn and stomach ulcers (such as cimetidine).
• Certain medicines used to treat coronary artery disease (angina pectoris) or high blood pressure (such as nicardipine).
• Certain medicines used to treat blood cancers (such as idelalisib).

Using Durogesic with antidepressants

The risk of side effects increases when used with certain antidepressants. There may be an interaction between Durogesic and these medicines, and the patient may experience changes in their mental state, such as agitation, hallucinations, and other effects, such as changes in blood pressure, rapid heartbeat, high temperature, excessive reflexes, coordination disorders, muscle stiffness, nausea, vomiting, and diarrhea (these may be symptoms of serotonin syndrome). In the case of concurrent use, the doctor may want to closely monitor the patient for such side effects, especially when starting treatment or changing the dose of the medicine.

Using Durogesic with centrally acting depressants, including alcohol and certain narcotics

Concomitant use of Durogesic and sedatives, such as benzodiazepines or derivatives, increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening. Therefore, concomitant use should only be considered when other treatment options are not possible.
If the doctor prescribes Durogesic with sedatives, the dose and duration of concomitant treatment should be limited by the doctor.
Inform your doctor about all sedatives being taken and strictly follow the doctor's dosage recommendations. It may be helpful to inform friends or relatives to be aware of the above symptoms. If such symptoms occur, consult a doctor.
Do not drink alcohol while using Durogesic without first discussing it with your attending doctor.

Surgical procedures

If the patient suspects they may undergo anesthesia, they should inform their doctor or dentist that they are using Durogesic.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Durogesic should not be used during pregnancy, unless discussed with a doctor.
Durogesic should not be used during the perinatal period, as it may cause respiratory disorders in the newborn.
Long-term use of Durogesic during pregnancy may cause withdrawal symptoms in the newborn (such as loud crying, trembling, seizures, poor feeding, and diarrhea), which can be life-threatening if not recognized and treated. If withdrawal symptoms are suspected in the child, consult a doctor immediately.
Durogesic should not be used during breastfeeding. Do not breastfeed for 3 days after removing the Durogesic patch. The medicine may pass into breast milk.

Driving and using machines

Durogesic may affect the ability to drive and use machines or tools, as it can cause drowsiness and dizziness. If these symptoms occur, do not drive or operate any machines or tools. Do not drive until you know how the medicine affects you.
Consult your doctor or pharmacist if you are unsure whether you can drive safely while using this medicine.

3. How to use Durogesic

Always use this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The doctor will decide which strength of Durogesic is suitable for the patient, based on the severity of the pain, the patient's overall condition, and the pain treatment used so far.
Before starting and regularly during treatment, the doctor will also discuss with the patient what to expect from using Durogesic, when and for how long to use it, when to consult a doctor, and when to stop using the medicine (see also section 2 "Withdrawal symptoms after stopping Durogesic").

Applying and changing patches

• Each patch contains enough medicine for 3 days (72 hours).
• Change the patch every third day, unless the doctor advises otherwise.
• Always remove the old patch beforeapplying a new one.
• Always change the patch at the same timeevery 3 days (72 hours).
• If the patient uses more than 1 patch, change all patches at the same time.
• Write down the day, date, and time the patch is applied to remember when to change it.
• The following table shows when to change the patch:

Patch applied on: Patch change on:

Monday
Thursday
Tuesday
Friday
Wednesday
Saturday
Thursday
Sunday
Friday
Monday
Saturday
Tuesday
Sunday
Wednesday

Where to apply the patch

Adults

• Apply patches to a flat area of the upper body or arm (avoiding joints).

Children

• To minimize the risk of the child touching or removing the patch, apply it to the upper back.
• Check frequently to ensure the patch is properly attached to the skin.
• It is essential that the child does not remove the patch and put it in their mouth, as this can be life-threatening or lead to death.
• Monitor the child closely for 48 hours after:
• applying the first patch
• applying a patch with a higher dose.
• The effect of the patch may be delayed after the first application. Therefore, before the full effect of the medicine is apparent, the child may receive additional pain relievers. The doctor will inform you about this.

Adults and children

Do not apply the patch:

• to the same place twice in a row
• to moving areas (joints), irritated, or damaged skin
• to very hairy skin. If there is hair, do not shave it (shaving irritates the skin). Instead, cut the hair as close to the skin as possible.

Applying the patch

Step 1: Preparing the skin

• Make sure the skin is completely dry, clean, and cool before applying the patch
• If the skin needs to be cleaned, do so with cold water
• Do not use soap or other cleansing products, oils, creams, lotions, or talcum powder before applying the patch
• Do not apply the patch immediately after a hot bath or shower.

Step 2: Opening the pouch

• Each patch is packaged in an individual pouch
• Tear the pouch at the notch indicated by the arrow
• Gently, completely tear or cut off one edge of the pouch (if using scissors, cut close to the edge to avoid damaging the patch)

• Hold the open pouch by both edges and stretch
• Remove the patch and apply it immediately
• Keep the empty pouch to use later for disposing of the used patch
• Each patch can only be used once
• Do not remove the patch from the pouch until you are ready to apply it
• Check if the patch is damaged
• Do not use patches that are cut, broken, or damaged in any way
• Never divide or cut patches.

Step 3: Removing the backing and applying the patch to the skin

• Make sure the clothing in the patch application area is loose; do not wear tight, elastic bands or bandages
• Carefully peel off one half of the protective liner from the center of the patch. Avoid touching the adhesive part of the patch
• Apply the adhesive part of the patch to the skin
• Remove the second part of the protective liner and press the entire patch firmly onto the skin with your hand
• Hold for at least 30 seconds. Make sure the patch is fully attached, especially at the edges.

Step 4: Removing the patch

• Immediately after removing the patch, fold it in half, adhesive side in
• Put it back in the original pouch and dispose of it according to the pharmacist's instructions
• Keep used patches out of sight and reach of children - even used patches still contain medicine that can be harmful to children and life-threatening.

Step 5: Washing hands

• Always wash your hands with clean water after applying or removing a patch.

Additional information about using Durogesic

Daily activities while using patches

• Patches are waterproof
• You can take a shower or bath, but do not rub the patch
• You can exercise or engage in sports with your doctor's permission while using the patch
• You can also swim while wearing the patch, but:
• Do not use prolonged warming baths or saunas
• Do not wear tight, elastic bands or bandages in the patch application area
• While using the patch, do not heat the patch application site with external heat sources, such as heated pads, electric blankets, hot water bottles, heated beds, heat lamps, or tanning beds. Do not sunbathe or use prolonged warming baths, saunas, or whirlpool baths. In these situations, there is a risk of increased release of the medicine from the patch.

How quickly will the patch work?

• The maximum effect of the first patch may be delayed.
• During the initial treatment period, the doctor may prescribe additional pain relievers
• After the initial treatment period, the patch should provide constant pain relief, so it may be possible to stop using other pain relievers. However, the doctor may occasionally recommend using additional pain relievers.

How long will the patient use the patches?

• Durogesic patches are used to treat chronic pain. The attending doctor will inform the patient about the expected duration of treatment.

If the pain worsens

• If the pain suddenly worsens after applying the last patch, check the patch. If it is no longer well attached or has fallen off, replace it (see also the section "If the patch comes off").
• If the pain worsens over time while using the patches, the doctor may prescribe a patch with a higher dose and (or) administer additional pain relievers
• If increasing the patch dose does not improve the pain, the doctor may decide to stop using the patches.

If more patches than prescribed are used or a patch with the wrong dose is used

If too many patches are used or a patch with the wrong dose is used, remove the patches immediately and consult a doctor as soon as possible.
Overdose symptoms include breathing disorders or shallow breathing, fatigue, extreme sleepiness, inability to think clearly, difficulty walking or talking, and feelings of fainting, dizziness, or confusion. Overdose can also cause brain disorders called toxic leukoencephalopathy.

If the patient forgets to change the patch

• Change the patch as soon as you remember and make a note of the day and time. The next patch should be changed after the standard 3 days (72 hours).
• If more time has passed since the patch change, consult your doctor, as additional pain relievers may be necessary, but do notapply an extra patch.

If the patch comes off

• If the patch comes off before the required change time, apply a new one in its place and make a note of the day and time. Apply the patch to a different area:
• on the upper body or arm
• on the upper back - in children
• Inform your doctor and leave the patch on for 3 days (72 hours)or as advised by your doctor, until the next scheduled patch change
• If the patch comes off repeatedly, consult your doctor, pharmacist, or nurse.

Stopping the use of patches

• Do not stop using this medicine abruptly. If the patient wants to stop using this medicine, they should first consult their doctor. The doctor will inform them how to do it; usually, this is done by gradually reducing the dose, so that any unpleasant withdrawal symptoms are minimized. See also section 2 "Withdrawal symptoms after stopping Durogesic".
• When stopping the use of patches, do not restart treatment without consulting a doctor. In such a situation, a different dose than before may be required.

If you have any further doubts about using the medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If the patient, their partner, or caregiver notices any of the following symptoms, remove the patch and consult a doctor or go to the nearest hospital immediately. Intensive medical care may be necessary.

Medical attention is required.

• Feeling excessively sleepy, slowed down, or having shallow breathing. Although rare, these breathing disorders can be life-threatening or lead to death, especially in people who have not previously used strong opioid pain medications (such as Durogesic or morphine). Follow the above advice and encourage the patient to move and talk as much as possible. (Uncommon, may occur in less than 1 in 100 people)
• Sudden swelling of the face or throat, severe irritation, redness, or blisters on the skin. These may be symptoms of a severe allergic reaction. (Frequency cannot be estimated from the available data)
• Seizures (Uncommon, may occur in less than 1 in 100 people)
• Decreased consciousness or loss of consciousness (Uncommon, may occur in less than 1 in 100 people).

The following side effects have also been reported

Very common side effects (may occur in more than 1 in 10 people):

• nausea, vomiting, constipation
• drowsiness
• feeling dizzy
• headache.

Common side effects (may occur in less than 1 in 10 people):

• allergic reaction
• loss of appetite
• insomnia
• depression
• feeling anxious or confused
• seeing, feeling, hearing, smelling things that do not exist (hallucinations)
• tremors or muscle spasms
• disorders of sensation, tingling, burning skin (paresthesia)
• dizziness
• rapid heartbeat or palpitations
• high blood pressure
• shortness of breath
• diarrhea
• dry mouth
• stomach pain or indigestion
• excessive sweating
• itching, rash, redness of the skin
• inability to urinate or fully empty the bladder
• feeling tired, weak, unwell
• feeling cold
• swelling of the limbs.

Uncommon side effects (may occur in less than 1 in 100 people):

• agitation or disorientation
• unusual state of happiness and increased activity (euphoria)
• decreased sensation, especially skin (hypoesthesia)
• memory loss
• blurred vision
• slow heartbeat or low blood pressure
• hypoxia (cyanosis)
• intestinal obstruction (ileus)
• itchy rash, allergic reaction, or other skin disorders at the patch application site
• flu-like symptoms
• feeling changes in body temperature
• fever
• muscle tremors
• erectile dysfunction or sexual function disorders
• difficulty swallowing.

Rare side effects (may occur in less than 1 in 1000 people):

• pupil constriction
• periodic breathing pauses (apnea)

The following side effects have also been reported, but their frequency is unknown:

• male sex hormone deficiency (androgen deficiency)
• delirium (symptoms may include agitation, anxiety, disorientation, confusion, fear, seeing or hearing things that do not exist, sleep disorders, nightmares)
• the patient may become dependent on Durogesic (see section 2).

A rash, redness, or mild itching may occur at the patch application site on the skin. These reactions are usually mild and resolve after removing the patch. If they do not resolve or the patch causes significant skin irritation, inform your doctor.
Repeated use of patches may lead to decreased effectiveness of the medicine (tolerance may develop) or the patient may become dependent on it.
After switching from other pain relievers to Durogesic or abruptly stopping Durogesic, the patient may experience withdrawal symptoms, such as nausea, vomiting, diarrhea, anxiety, and chills. Inform your doctor immediately if such symptoms occur.
In newborns whose mothers have used Durogesic chronically during pregnancy, cases of withdrawal symptoms have been observed.

Reporting side effects

If side effects occur, including any not listed in this leaflet, inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of this medicine.

5. How to store Durogesic

Where to store the patches

Unused and used Durogesic patches should be stored in a place that is out of sight and reach of children.
Store in the original packaging to protect from light.
There are no special storage temperature requirements for this medicine.
The medicine should be stored in a safe and protected place, inaccessible to other people. It can cause serious harm and lead to death if used accidentally or intentionally by people who have not been prescribed it.

How long can Durogesic be stored

Do not use this medicine after the expiration date stated on the protective pouch and outer packaging after EXP. The expiration date refers to the last day of the month stated.
If the expiration date has passed, return unused patches to the pharmacy.
The medicine should be stored in closed pouches in the original packaging, without special requirements.

How to dispose of used and unused patches

Accidental attachment of a used or unused patch to another person's skin, especially a child, can be fatal.
Used patches should be folded in half, with the adhesive sides together, placed in the original pouch, and then disposed of in a place that is out of sight and reach of others, especially children, until disposal. Ask your pharmacist how to dispose of medicines that are no longer needed.
Do not dispose of medicines in the drain or household waste. This will help protect the environment.

6. Contents of the packaging and other information

What Durogesic contains

• The active substance of Durogesic is fentanyl. Durogesic, transdermal system, patch 12 µg/h contains 2.1 mg of fentanyl and releases 12 micrograms of the medicine per hour. Durogesic, transdermal system, patch 25 µg/h contains 4.2 mg of fentanyl and releases 25 micrograms of the medicine per hour. Durogesic, transdermal system, patch 50 µg/h contains 8.4 mg of fentanyl and releases 50 micrograms of the medicine per hour. Durogesic, transdermal system, patch 75 µg/h contains 12.6 mg of fentanyl and releases 75 micrograms of the medicine per hour. Durogesic, transdermal system, patch 100 µg/h contains 16.8 mg of fentanyl and releases 100 micrograms of the medicine per hour.

Other ingredients (excipients) of the patch are:

The outer layer, foil: polyester and ethylene-vinyl acetate copolymer.
The protective layer, foil: siliconized polyester.
The layer containing the active substance: acrylic adhesive.
Printing inks (on the outer layer):
Durogesic 12 µg/h also contains orange printing ink.
Durogesic 25 µg/h also contains red printing ink.
Durogesic 50 µg/h also contains green printing ink.
Durogesic 75 µg/h also contains blue printing ink.
Durogesic 100 µg/h also contains gray printing ink.

What Durogesic looks like and contents of the packaging

Durogesic 12 µg/h
Durogesic is a semi-transparent, rectangular patch with rounded corners. Each patch has an area of 5.25 cm and has an orange border printed with "DUROGESIC 12 µg fentanyl/h".
Durogesic 25 µg/h
Durogesic is a semi-transparent, rectangular patch with rounded corners. Each patch has an area of 10.5 cm and has a red border printed with "DUROGESIC 25 µg fentanyl/h".
Durogesic 50 µg/h
Durogesic is a semi-transparent, rectangular patch with rounded corners. Each patch has an area of 21.0 cm and has a green border printed with "DUROGESIC 50 µg fentanyl/h".
Durogesic 75 µg/h
Durogesic is a semi-transparent, rectangular patch with rounded corners. Each patch has an area of 31.5 cm and has a blue border printed with "DUROGESIC 75 µg fentanyl/h".
Durogesic 100 µg/h
Durogesic is a semi-transparent, rectangular patch with rounded corners. Each patch has an area of 42.0 cm and has a gray border printed with "DUROGESIC 100 µg fentanyl/h".
The medicine is supplied in cardboard boxes containing 5 individually packaged patches in heat-sealed pouches (made of acrylonitrile or cyclic olefin copolymer).

Marketing authorization holder:

Janssen-Cilag International NV
Turnhoutseweg 30
B-2340 Beerse
Belgium

Manufacturer:

Janssen-Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse
Belgium
To obtain more detailed information about this medicine, please contact the local representative of the marketing authorization holder:
Janssen-Cilag Poland Sp. z o.o.
phone: +48 22 237 60 00

This medicine is authorized in the Member States of the European Economic Area

Economically and in the United Kingdom (Northern Ireland) under the following names:

Date of the last update of the leaflet: 10/2024

Other sources of information

Detailed information about this medicinal product is available on the website of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products www.urpl.gov.pl